A long-lasting cholinesterase inhibitor affecting neural and behavioral processes

[1]  R. Whelpton,et al.  Bioavailability of oral physostigmine. , 1985, The New England journal of medicine.

[2]  David M. A. Mann,et al.  The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.

[3]  R. Whelpton,et al.  PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL DOSES , 1985, The Lancet.

[4]  C. Castellano,et al.  Naltrexone-reversible effects of flunitrazepam on locomotor activity and passive avoidance behaviour in mice. , 1984, European journal of pharmacology.

[5]  S. Zornetzer,et al.  The mnemon and its juices: neuromodulation of memory processes. , 1983, Behavioral and neural biology.

[6]  B. Reisberg,et al.  Effects of naloxone in senile dementia: a double-blind trial. , 1983, New England Journal of Medicine.

[7]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[8]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[9]  S. Corkin.  Acetylcholine, aging and Alzheimer's disease Implications for treatment , 1981, Trends in Neurosciences.

[10]  R. Wurtman,et al.  Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland. , 1978, Science.

[11]  R. Wurtman,et al.  Brain acetylcholine: control by dietary choline. , 1976, Science.

[12]  A. Oliverio,et al.  Early malnutrition and postnatal changes in brain and behavior in the mouse , 1976, Brain Research.

[13]  H. Baumgarten,et al.  Reactions of amines. XVIII. Oxidative rearrangement of amides with lead tetraacetate , 1975 .

[14]  Conn Nk,et al.  Letter: Avirulent corynebacteria. , 1975 .

[15]  A. Oliverio.  Effects of mecamylamine on avoidance conditioning and maze learning of mice. , 1966, The Journal of pharmacology and experimental therapeutics.

[16]  H. Baumgarten,et al.  Reactions of Amines. XIV. An Oxidative Rearrangement of Amides1,2 , 1965 .

[17]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[18]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[19]  K. Davis,et al.  Physostigmine in patients with Alzheimer's disease. , 1986, Psychopharmacology bulletin.

[20]  K. Davis,et al.  Oral physostigmine treatment of patients with Alzheimer's disease. , 1985, The American journal of psychiatry.

[21]  J A Deutsch,et al.  The physiological basis of memory. , 1969, Annual review of psychology.